Investment firm Sequoia Capital led a $200m Series E round in Benchling, a life sciences R&D cloud, with participation from Altimeter Capital, Byers Capital, Elad Gil, Thrive Capital, Benchmark, Menlo Ventures, Alkeon Capital, ICONIQ, Lux Capital, Spark Capital and Lead Edge Capital. "Recent breakthroughs in biology have the potential to transform the world in the same way that computing and the internet did. We are relying on scientists to rewrite the medicines we take, the food we eat, and the fuels that power our lives. We are excited to partner with Benchling as they build the foundational software infrastructure for the scientists redefining the world," Patrick Fu, Sequoia Capital Managing Partner.